300 related articles for article (PubMed ID: 20536466)
1. Combination strategies for enhancing the efficacy of immunotherapy in cancer patients.
Moschella F; Proietti E; Capone I; Belardelli F
Ann N Y Acad Sci; 2010 Apr; 1194():169-78. PubMed ID: 20536466
[TBL] [Abstract][Full Text] [Related]
2. In silico prediction of cancer immunogens: current state of the art.
Doytchinova IA; Flower DR
BMC Immunol; 2018 Mar; 19(1):11. PubMed ID: 29544447
[TBL] [Abstract][Full Text] [Related]
3. Current approaches in dendritic cell generation and future implications for cancer immunotherapy.
Tuyaerts S; Aerts JL; Corthals J; Neyns B; Heirman C; Breckpot K; Thielemans K; Bonehill A
Cancer Immunol Immunother; 2007 Oct; 56(10):1513-37. PubMed ID: 17503040
[TBL] [Abstract][Full Text] [Related]
4. Combinatorial treatments including vaccines, chemotherapy and monoclonal antibodies for cancer therapy.
Baxevanis CN; Perez SA; Papamichail M
Cancer Immunol Immunother; 2009 Mar; 58(3):317-24. PubMed ID: 18704409
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant immunotherapy for solid tumors: from promise to clinical application.
Mocellin S; Rossi CR; Lise M; Marincola FM
Cancer Immunol Immunother; 2002 Dec; 51(11-12):583-95. PubMed ID: 12439603
[TBL] [Abstract][Full Text] [Related]
6. Vaccine adjuvants as potential cancer immunotherapeutics.
Temizoz B; Kuroda E; Ishii KJ
Int Immunol; 2016 Jul; 28(7):329-38. PubMed ID: 27006304
[TBL] [Abstract][Full Text] [Related]
7. CIMT 2009: report on the seventh annual meeting of the association for immunotherapy of cancer. June 3-5, Mainz, Germany.
Diken M; Widenmeyer M; Gouttefangeas C; Welters MJ; Britten CM
Cancer Immunol Immunother; 2010 Sep; 59(9):1417-23. PubMed ID: 19771427
[No Abstract] [Full Text] [Related]
8. Strategies for immune therapy: Würzburg, Germany, 29 February-3 March 2004.
Pawelec G; Gouttefangeas C
Cancer Immunol Immunother; 2004 Aug; 53(8):755-8. PubMed ID: 15133632
[No Abstract] [Full Text] [Related]
9. Combinations of anticancer drugs and immunotherapy.
Mitchell MS
Cancer Immunol Immunother; 2003 Nov; 52(11):686-92. PubMed ID: 12942200
[TBL] [Abstract][Full Text] [Related]
10. DNA vaccines for cancer too.
Yu M; Finn OJ
Cancer Immunol Immunother; 2006 Feb; 55(2):119-30. PubMed ID: 16032397
[No Abstract] [Full Text] [Related]
11. Mechanism of synergistic effect of chemotherapy and immunotherapy of cancer.
Ramakrishnan R; Gabrilovich DI
Cancer Immunol Immunother; 2011 Mar; 60(3):419-23. PubMed ID: 20976448
[TBL] [Abstract][Full Text] [Related]
12. Establishing the applicability of cancer vaccines in combination with chemotherapeutic entities: current aspect and achievable prospects.
Kothari N; Postwala H; Pandya A; Shah A; Shah Y; Chorawala MR
Med Oncol; 2023 Apr; 40(5):135. PubMed ID: 37014489
[TBL] [Abstract][Full Text] [Related]
13. Report on the sixth annual meeting of the Association for Immunotherapy of Cancer (CIMT), May 15 and 16, 2008 in Mainz, Germany.
Welters MJ; van Montfoort N; Khan S; Meyer RG; Britten CM
Cancer Immunol Immunother; 2009 May; 58(5):777-87. PubMed ID: 18982325
[No Abstract] [Full Text] [Related]
14. International meeting "Immunotherapy of cancer: challenges and needs".
Ferrantini M; Capone I; Marincola FM; Parmiani G; Belardelli F
Cancer Immunol Immunother; 2007 Apr; 56(4):581-5. PubMed ID: 17131119
[TBL] [Abstract][Full Text] [Related]
15. Second International Conference on Cancer Vaccines/Adjuvants/Delivery for the Next Decade (CVADD): Heidelberg, Germany, 10-12 October 2007.
Schirrmacher V; Beckhove P; Fournier P; Umansky V
Cancer Immunol Immunother; 2008 Sep; 57(9):1421-7. PubMed ID: 18270701
[No Abstract] [Full Text] [Related]
16. How should clinical data be included in experimental studies of cancer immunology?
Gjertsen BT; Bruserud Ø
Cancer Immunol Immunother; 2004 Aug; 53(8):677-80. PubMed ID: 15069584
[TBL] [Abstract][Full Text] [Related]
17. Toward next-generation cancer immunotherapy: 10th annual meeting of the Association for Cancer Immunotherapy (CIMT), Mainz, Germany, May 23-25, 2012.
Kloke BP; Kutscher S; Rae R; Kvistborg P; Britten CM; Hadrup SR
Cancer Immunol Immunother; 2013 May; 62(5):975-81. PubMed ID: 23299564
[No Abstract] [Full Text] [Related]
18. Ninth annual meeting of the Association for Cancer Immunotherapy (CIMT 2011), May 25-27, 2011, Mainz, Germany.
Hobohm K; Seppmann T; Britten CM; Hoff H
Cancer Immunol Immunother; 2012 Jan; 61(1):137-43. PubMed ID: 22048716
[No Abstract] [Full Text] [Related]
19. Second International Symposium on Cancer Biology (ISCB), November 14-16, 2011, at the National Institute of Immunology, New Delhi, India.
Suri A; Saini S; Gupta N
Cancer Immunol Immunother; 2012 Oct; 61(10):1877-82. PubMed ID: 22806092
[No Abstract] [Full Text] [Related]
20. Advances, opportunities and challenges in developing therapeutic cancer vaccines.
Duan Z; Yang D; Yuan P; Dai X; Chen G; Wu D
Crit Rev Oncol Hematol; 2024 Jan; 193():104198. PubMed ID: 37949152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
